Autism - Related Disorders - References

1. Filipek, P.A. (2005). Medical aspects of autism. In F. Volkmar et al. (Eds.), Handbook of Autism and Pervasive Developmental Disorders (pp.534-578). Hoboken, NJ: John Wiley & Sons. (pg. 543)
2. Volkmar, F.R., Wiesner, L.A., & Westphal, A. (2006). Healthcare issues for children on the autism spectrum. Current Opinion in Psychiatry, 19, 361-366.  Abstract
3. Filipek, P.A. (2005). Medical aspects of autism. In F. Volkmar et al. (Eds.), Handbook of Autism and Pervasive Developmental Disorders (pp.534-578). Hoboken, NJ: John Wiley & Sons. (pg. 543)
4. Smalley, S.L. (1998). Autism and tuberous sclerosis. Journal of Autism and Developmental Disorders, 28(5), 407-414.  Abstract
5. Volkmar, F.R., Wiesner, L.A., & Westphal, A. (2006). Healthcare issues for children on the autism spectrum. Current Opinion in Psychiatry, 19, 361-366.  Abstract
6. Smalley, S.L. (1998). Autism and tuberous sclerosis. Journal of Autism and Developmental Disorders, 28(5), 407-414.  Abstract
7. Bolton, P.F., Park, R.J., Higgins, N.P., Griffiths, P.D., & Pickles, A. (2002). Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain, 125, 1247-1255. (pg. 1247)  Abstract
8. Jambaque, I., Chiron, C., Dumas, C., Mumford, J, & Dulac, O. (2000). Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Research, 38, 151-160.  Abstract
9. Zafeiriou, D.I., Ververi, A., & Vargiami E. (2006). Childhood autism and associated comorbidities. Brain & Development, in press, doi:10.1016/j.braindev.2006.09.03 – available on-line 11/7/06.  Abstract
10. Bolton, P.F., Park, R.J., Higgins, N.P., Griffiths, P.D., & Pickles, A. (2002). Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain, 125, 1247-1255. (pg. 1247)  Abstract
11. U.S. Centers for Disease Control and Prevention. (2006). Causes of Fragile X Syndrome. Retrieved on December 26, 2006. Website: http://www.cdc.gov/ncbddd/single_gene/fragilex_causes.htm
12. U.S. Centers for Disease Control and Prevention. (2006). Fragile X Syndrome. Retrieved on December 26, 2006. Website: http://www.cdc.gov/ncbddd/single_gene/fragilex.htm
13. Hatton, D.D., Sideris, J., Skinner, M., Mankowski, J., Bailey, D.B., Roberts, J., & Mirrett, P. (2006). Autistic behavior in children with Fragile X syndrome: Prevalence, stability, and the impact of FMRP. American Journal of Medical Genetics Part A, 140A, 1804-1813.  Abstract
14. Zafeiriou, D.I., Ververi, A., & Vargiami E. (2006). Childhood autism and associated comorbidities. Brain & Development, in press, doi:10.1016/j.braindev.2006.09.03 – available on-line 11/7/06.  Abstract
15. Bailey, D.B., Hatton, D.D., Skinner, M., & Mesibov, G. (2001). Autistic behavior, FMR1 protein, and developmental trajectories in young males with Fragile X syndrome. Journal of Autism and Developmental Disorders, 31(2), 165-174.  Abstract
16. Volkmar, F.R., Wiesner, L.A., & Westphal, A. (2006). Healthcare issues for children on the autism spectrum. Current Opinion in Psychiatry, 19, 361-366.  Abstract
17. Hagerman, R.J. (2006). Lessons from Fragile X regarding neurobiology, autism, and neurodegeneration. Developmental and Behavioral Pediatrics, 27(1), 63-74.  Abstract
18. Fombonne, E. (2005). Epidemiological studies of pervasive developmental disorders. In F. Volkmar et al. (Eds.), Handbook of Autism and Pervasive Developmental Disorders (pp.42-69). Hoboken, NJ: John Wiley & Sons. (pg. 51)
19. Belmonte, M.K., & Bourgeron, T. (2006). Fragile X syndrome and autism at the intersection of genetic and neural networks. Nature Neuroscience, 9(10), 1221-1225.  Abstract

Return to Autism - Related Disorders